These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 36853587)

  • 21. Age-related prescription medication utilization for the -management of sickle cell disease among Texas Medicaid patients.
    Shukla N; Barner JC; Lawson KA; Rascati KL
    J Opioid Manag; 2021; 17(4):301-310. PubMed ID: 34533824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug Therapies for the Management of Sickle Cell Disease.
    Rai P; Ataga KI
    F1000Res; 2020; 9():. PubMed ID: 32765834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Effectiveness of Common Interventions in the Management of Sickle Cell Disease in Primary Care Settings: A Review.
    Mbaezue RN; Okafor AT; Nkwocha BI; Ibeneme CN; Opara AC; Akahara DE; Okobi OE
    Cureus; 2023 Sep; 15(9):e44780. PubMed ID: 37809245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
    Estcourt LJ; Kimber C; Hopewell S; Trivella M; Doree C; Abboud MR
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD012389. PubMed ID: 32250453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcomes of COVID-19 in patients with sickle cell disease and sickle cell trait: A critical appraisal of the literature.
    Hoogenboom WS; Alamuri TT; McMahon DM; Balanchivadze N; Dabak V; Mitchell WB; Morrone KB; Manwani D; Duong TQ
    Blood Rev; 2022 May; 53():100911. PubMed ID: 34838342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Streptococcus pneumoniae sepsis and meningitis during the penicillin prophylaxis era in children with sickle cell disease.
    Hord J; Byrd R; Stowe L; Windsor B; Smith-Whitley K
    J Pediatr Hematol Oncol; 2002; 24(6):470-2. PubMed ID: 12218595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hydroxyurea (hydroxycarbamide) for sickle cell disease.
    Nevitt SJ; Jones AP; Howard J
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002202. PubMed ID: 28426137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC.
    Drawz P; Ayyappan S; Nouraie M; Saraf S; Gordeuk V; Hostetter T; Gladwin MT; Little J
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):207-15. PubMed ID: 26672090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current understanding in the management of sickle cell disease.
    Inati A; Chabtini L; Mounayar M; Taher A
    Hemoglobin; 2009; 33 Suppl 1():S107-15. PubMed ID: 20001613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phytomedicines (medicines derived from plants) for sickle cell disease.
    Oniyangi O; Cohall DH
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD004448. PubMed ID: 32977351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sickle cell disease: current activities, public health implications, and future directions.
    Creary M; Williamson D; Kulkarni R
    J Womens Health (Larchmt); 2007 Jun; 16(5):575-82. PubMed ID: 17627395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimated Life Expectancy and Income of Patients With Sickle Cell Disease Compared With Those Without Sickle Cell Disease.
    Lubeck D; Agodoa I; Bhakta N; Danese M; Pappu K; Howard R; Gleeson M; Halperin M; Lanzkron S
    JAMA Netw Open; 2019 Nov; 2(11):e1915374. PubMed ID: 31730182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease.
    Rankine-Mullings AE; Owusu-Ofori S
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD003427. PubMed ID: 33724440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological interventions for painful sickle cell vaso-occlusive crises in adults.
    Cooper TE; Hambleton IR; Ballas SK; Johnston BA; Wiffen PJ
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31742673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient-Reported Experiences in Voxelotor-Treated Children and Adults with Sickle Cell Disease: A Semistructured Interview Study.
    Brown C; Idowu M; Drachtman R; Beaubrun A; Agodoa I; Nguyen A; Lipman K; Moshkovich O; Murphy R; Bellenger MA; Smith W
    Biomed Res Int; 2023; 2023():7533111. PubMed ID: 36748060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sickle cell disease: a malady beyond a hemoglobin defect in cerebrovascular disease.
    Ansari J; Moufarrej YE; Pawlinski R; Gavins FNE
    Expert Rev Hematol; 2018 Jan; 11(1):45-55. PubMed ID: 29207881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growing beyond sickle cell disease: A metasynthesis of children, adolescents, and young adult experiences living with sickle cell disease.
    Coco M; Henderson WA; Park CL; Starkweather AR
    Res Nurs Health; 2023 Jun; 46(3):299-312. PubMed ID: 37036038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First Ischemic Stroke in Sickle-Cell Disease: Are There Any Adult Specificities?
    Calvet D; Bernaudin F; Gueguen A; Hosseini H; Habibi A; Galactéros F; Bartolucci P
    Stroke; 2015 Aug; 46(8):2315-7. PubMed ID: 26173728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sickle cell disease: progress towards combination drug therapy.
    Pace BS; Starlard-Davenport A; Kutlar A
    Br J Haematol; 2021 Jul; 194(2):240-251. PubMed ID: 33471938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Qualitative Study of Chronic Pain and Self-Management in Adults with Sickle Cell Disease.
    Matthie N; Ross D; Sinha C; Khemani K; Bakshi N; Krishnamurti L
    J Natl Med Assoc; 2019 Apr; 111(2):158-168. PubMed ID: 30266214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.